In Reply: Sentinel Lymph Node Biopsy in Melanoma

被引:0
作者
Ulrike Leiter
Claus Garbe
机构
[1] Eberhard-Karls-University,Center for Dermato
[2] James Cook University,Oncology, Department of Dermatology
来源
Annals of Surgical Oncology | 2011年 / 18卷
关键词
Melanoma; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Melanoma Patient; Sentinel Lymph Node Procedure;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:598 / 599
页数:1
相关论文
共 53 条
[1]  
Medalie N(2004)Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastasized to a lymph node and therefore should be abandoned now Br J Dermatol. 151 298-307
[2]  
Ackerman AB(2003)Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma metastatic to a lymph node: an assertion based on comprehensive, critical analysis: part II Am J Dermatopathol. 25 473-484
[3]  
Medalie NS(2004)The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma Br J Dermatol. 151 308-319
[4]  
Ackerman AB(2000)The argument against sentinel node biopsy for malignant melanoma BMJ. 321 3-4
[5]  
Morton DL(2004)Sentinel lymph node biopsy: not yet standard of care for melanoma BMJ. 329 170-171
[6]  
Cochran AJ(2001)Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment Mod Pathol. 14 604-608
[7]  
Thomas JM(2006)Tumour-induced immune modulation of sentinel lymph nodes Nat Rev Immunol. 6 659-670
[8]  
Patocskai EJ(2000)Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening J Natl Cancer Inst. 92 1280-1282
[9]  
Thomas JM(2008)Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival Am J Epidemiol. 168 98-104
[10]  
Clark MA(1981)Elimination of “lead time” bias in assessing the effect of early breast cancer diagnosis Am J Epidemiol. 113 93-97